HLCM
OGN icon

Hi-Line Capital Management’s Organon & Co OGN Stock Holding History

Hi-Line Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,280
Closed -$501K – 40
2023
Q1 		$501K Buy
21,280
+922
+5% +$24.8K 0.17% 40
2022
Q4 		$569K Buy
+20,358
New +$521K 0.18% 42

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Hi-Line Capital Management's OGN Position: Q2 2023 in Review

Hi-Line Capital Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 21,280 shares — an estimated $501K sold.

Hi-Line Capital Management first reported a position in OGN in Q4 2022 and held it in 2 quarters. The position peaked at $569K in Q4 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Hi-Line Capital Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Hi-Line Capital Management sold 21,280 Organon & Co shares in Q2 2023, an estimated $501K.
  • Hi-Line Capital Management first reported a position in Organon & Co in Q4 2022 and held it in 2 quarters.
  • Hi-Line Capital Management's Organon & Co position peaked at $569K in Q4 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Hi-Line Capital Management's 13F filing for Q2 2023, filed 1 Aug 2023.